Funding allows MSDx to launch test kits to the researchers for use in multiple sclerosis research.Continue reading
C-Path founder Raymond L. Woosley, MD, PhD announces retirement plans.
TGen Drug Development (TD2) and Flagship Biosciences offer combined oncology and pathology services for pharmaceutical and biotech clients.Continue reading
Flagship teams with Angela Wyatt Dermatology to offer dermatopathology clinical trials and discovery services to pharma and biotech firms.Continue reading
Animal Health Consulting and Flagship Biosciences team to offer virtual pathology in animal health product development.Continue reading
New Innovation Enables Physicians and Interventionalists to Reposition Device for Ideal Placement in Treating Abdominal Aortic AneurysmsContinue reading